Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel

AB22002 - A dose-ranging study to investigate efficacy and safety of buntanetap in participants with early AD

Clinical Trial Grant
Duke Scholars

Awarded By

Annovis Bio, Inc.

Start Date

December 7, 2022

End Date

August 8, 2024
 

Awarded By

Annovis Bio, Inc.

Start Date

December 7, 2022

End Date

August 8, 2024